These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 19176377)

  • 1. Suppression of cFLIP by lupeol, a dietary triterpene, is sufficient to overcome resistance to TRAIL-mediated apoptosis in chemoresistant human pancreatic cancer cells.
    Murtaza I; Saleem M; Adhami VM; Hafeez BB; Mukhtar H
    Cancer Res; 2009 Feb; 69(3):1156-65. PubMed ID: 19176377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lupeol triterpene, a novel diet-based microtubule targeting agent: disrupts survivin/cFLIP activation in prostate cancer cells.
    Saleem M; Murtaza I; Witkowsky O; Kohl AM; Maddodi N
    Biochem Biophys Res Commun; 2009 Oct; 388(3):576-82. PubMed ID: 19683515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-treatment of birinapant with TRAIL synergistically induces apoptosis by downregulating cFLIP(L) in MDA-MB-453 cell lines.
    Park EJ; Kim HD; Choi EK; Hoe KL; Kim DU
    Biochem Biophys Res Commun; 2020 Dec; 533(3):289-295. PubMed ID: 32958259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis.
    Saleem M; Maddodi N; Abu Zaid M; Khan N; bin Hafeez B; Asim M; Suh Y; Yun JM; Setaluri V; Mukhtar H
    Clin Cancer Res; 2008 Apr; 14(7):2119-27. PubMed ID: 18381953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition and apoptosis induced by lupeol, a dietary triterpene, in human hepatocellular carcinoma cells.
    He Y; Liu F; Zhang L; Wu Y; Hu B; Zhang Y; Li Y; Liu H
    Biol Pharm Bull; 2011; 34(4):517-22. PubMed ID: 21467639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quercetin sensitizes pancreatic cancer cells to TRAIL-induced apoptosis through JNK-mediated cFLIP turnover.
    Kim JH; Kim MJ; Choi KC; Son J
    Int J Biochem Cell Biol; 2016 Sep; 78():327-334. PubMed ID: 27477310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Itch/AIP4-independent proteasomal degradation of cFLIP induced by the histone deacetylase inhibitor SAHA sensitizes breast tumour cells to TRAIL.
    Yerbes R; López-Rivas A
    Invest New Drugs; 2012 Apr; 30(2):541-7. PubMed ID: 21107885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis.
    Geserick P; Drewniok C; Hupe M; Haas TL; Diessenbacher P; Sprick MR; Schön MP; Henkler F; Gollnick H; Walczak H; Leverkus M
    Oncogene; 2008 May; 27(22):3211-20. PubMed ID: 18084329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation.
    Rosato RR; Almenara JA; Coe S; Grant S
    Cancer Res; 2007 Oct; 67(19):9490-500. PubMed ID: 17909059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells.
    Mori T; Doi R; Kida A; Nagai K; Kami K; Ito D; Toyoda E; Kawaguchi Y; Uemoto S
    J Surg Res; 2007 Oct; 142(2):281-6. PubMed ID: 17640673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor Perifosine in acute myelogenous leukemia cells.
    Tazzari PL; Tabellini G; Ricci F; Papa V; Bortul R; Chiarini F; Evangelisti C; Martinelli G; Bontadini A; Cocco L; McCubrey JA; Martelli AM
    Cancer Res; 2008 Nov; 68(22):9394-403. PubMed ID: 19010914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells.
    Wang P; Zhang J; Bellail A; Jiang W; Hugh J; Kneteman NM; Hao C
    Cell Signal; 2007 Nov; 19(11):2237-46. PubMed ID: 17693058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
    Hari Y; Harashima N; Tajima Y; Harada M
    Oncotarget; 2015 Dec; 6(39):41902-15. PubMed ID: 26506422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plumbagin enhances TRAIL-induced apoptosis of human leukemic Kasumi‑1 cells through upregulation of TRAIL death receptor expression, activation of caspase-8 and inhibition of cFLIP.
    Kong X; Luo J; Xu T; Zhou Y; Pan Z; Xie Y; Zhao L; Lu Y; Han X; Li Z; Liu L
    Oncol Rep; 2017 Jun; 37(6):3423-3432. PubMed ID: 28498435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.
    Yu R; Albarenque SM; Cool RH; Quax WJ; Mohr A; Zwacka RM
    Cancer Biol Ther; 2014; 15(12):1658-66. PubMed ID: 25482930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamine-mediated epigenetic regulation of cFLIP underlies resistance to TRAIL in pancreatic cancer.
    Kim JH; Lee J; Im SS; Kim B; Kim EY; Min HJ; Heo J; Chang EJ; Choi KC; Shin DM; Son J
    Exp Mol Med; 2024 Apr; 56(4):1013-1026. PubMed ID: 38684915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP.
    Bangert A; Cristofanon S; Eckhardt I; Abhari BA; Kolodziej S; Häcker S; Vellanki SH; Lausen J; Debatin KM; Fulda S
    Oncogene; 2012 Nov; 31(44):4677-88. PubMed ID: 22266862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rocaglamide overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells by attenuating the inhibition of caspase-8 through cellular FLICE-like-inhibitory protein downregulation.
    Luan Z; He Y; He F; Chen Z
    Mol Med Rep; 2015 Jan; 11(1):203-11. PubMed ID: 25333816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF Apoptosis Protection Fraction (TAPF) prevents apoptosis induced by TNF, but not by Fas or TRAIL, via NF-κB-induced increase in cFLIP.
    Seol JY; Mihich E; Berleth ES
    Cytokine; 2015 Oct; 75(2):321-9. PubMed ID: 26198031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human embryonic and induced pluripotent stem cells express TRAIL receptors and can be sensitized to TRAIL-induced apoptosis.
    Vinarsky V; Krivanek J; Rankel L; Nahacka Z; Barta T; Jaros J; Andera L; Hampl A
    Stem Cells Dev; 2013 Nov; 22(22):2964-74. PubMed ID: 23806100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.